The Kidney Dialysis Foundation reported this week that electricity bills across its four Singapore centres have jumped by around S$2,000 a month, driven by rising energy costs linked to the Middle East supply chain disruption, according to CNA. Haemodialysis, which filters waste from the blood using a machine and must be performed three times a week for the rest of a patient's life, can cost more than S$2,000 a month without subsidies. Around nine in ten KDF patients are fully subsidised by the government and charitable support. For those who are not, out-of-pocket costs are currently capped at around S$200 a month.
For most Singapore employers, the immediate reaction to a story like this is relief. Dialysis is a catastrophic healthcare cost, and the subsidy framework means most patients are protected.
But the story raises a question that most employers have never asked about their group medical programme: if one of your employees develops a chronic illness that requires ongoing, recurring treatment, what does your group medical policy actually cover, and for how long?
The answer, in most cases, is less than employers assume.
What group medical insurance is designed for
Group Hospital and Surgical (GHS) insurance, the most common form of employer-provided medical benefit in Singapore, is designed around acute healthcare events. A hospitalisation for surgery. A day procedure. An emergency admission. The policy is structured with annual claim limits, per-condition limits, and per-admission limits that reflect the cost profile of these events.
What GHS is generally not designed for is a chronic condition requiring frequent, recurring, long-term treatment. Kidney failure requiring three dialysis sessions a week. Cancer requiring months of chemotherapy and follow-up admissions. An autoimmune condition requiring regular specialist consultations and infusions. Each of these creates a claims pattern that is fundamentally different from the acute surgical admission the GHS policy was priced and structured to cover.
The practical consequences emerge in two ways.
First, annual and per-condition claim limits. A GHS policy with a S$20,000 annual limit and a S$10,000 per-condition limit provides meaningful cover for a single surgical admission. For a patient undergoing haemodialysis three times a week, the annual cost without subsidy exceeds S$24,000. The per-condition limit is exhausted within months. After that, the employee is either relying on subsidies, drawing on personal savings, or hoping that a personal Integrated Shield Plan picks up what the employer policy does not.
Second, the chronic illness gap is invisible until it is triggered. An employer reviewing the group medical programme at renewal sees aggregate claims data and renewal premiums. They do not see the individual employee who quietly exhausted their per-condition limit in April and has been paying out of pocket since May without telling anyone.
What happens when the employer policy runs out
For an employee with both an employer GHS policy and a personal Integrated Shield Plan (IP), the interaction between the two policies determines their actual out-of-pocket cost.
As a general rule, employer group insurance pays first, up to the employer policy limit. The personal IP then applies to the remaining eligible balance, subject to the policy's own deductible, co-insurance, rider terms, and claim limits. The indemnity principle means total reimbursement across all policies cannot exceed the actual hospital bill.
For a chronic illness patient, this interaction is more complex than a single hospitalisation claim. Each dialysis session, each chemotherapy admission, and each inpatient stay generates a separate claim event. The deductible on the IP, which ranges from S$1,500 to S$3,500 per policy year depending on the ward class under MOH's framework, applies once per policy year rather than per admission. For a patient with multiple admissions in a year, the deductible is absorbed early, and the IP covers subsequent eligible claims more fully.
From 1 April 2026, new IP riders sold in Singapore may no longer fully cover the minimum deductible, and the annual co-payment cap for new riders has risen to a minimum of S$6,000 per year, according to MOH's updated requirements for Integrated Shield Plan riders. Employees who purchased their IP rider before this change may be in a more favourable position for managing chronic illness costs than those who purchased after. Employees reviewing their personal IP should seek advice from a qualified financial adviser on the specific terms of their plan and rider.
The leaving-the-job scenario
One of the most practically significant gaps in employer group medical coverage for chronic illness is what happens when the employee leaves.
Employer GHS coverage is tied to active employment. When an employee resigns, is retrenched, or retires, the employer policy terminates. For an otherwise healthy 35-year-old who changes jobs, this gap is brief and largely irrelevant. For an employee mid-treatment for a chronic condition, the loss of employer coverage is a material financial event.
A personal IP continues as long as the policyholder pays the premiums. For the employee mid-dialysis or mid-chemotherapy who loses their job, the personal IP becomes the primary remaining private insurance layer. Without it, the employee is reliant entirely on the public subsidy framework and their own savings.
This scenario creates a specific obligation for employers who care about the welfare of their workforce: ensuring that employees understand the limits of their employer group medical coverage, and are encouraged to hold personal IP alongside it, before a chronic illness makes the gap visible.
What the employer can actually do
Group medical insurance is the foundation of the employee benefits programme. It is not a substitute for personal health insurance, and communicating that distinction clearly is part of running a responsible benefits programme.
Three things are worth reviewing in the context of chronic illness coverage.
Review per-condition limits against realistic chronic illness costs. A per-condition limit set years ago may not reflect current treatment costs for conditions like renal failure, oncology, or autoimmune disease. If the limit is materially below the annual cost of a realistic chronic illness scenario, employees are carrying more uninsured exposure than the benefits summary suggests.
Ensure the programme includes adequate inpatient and specialist consultation cover. Many chronic illness patients move between inpatient admissions and outpatient specialist consultations in a cycle. A GHS policy that covers inpatient admissions well but has a low or no outpatient specialist sub-limit leaves a gap in exactly the phase of treatment that generates the most frequent contact with the healthcare system.
Communicate the limits of the employer policy clearly at onboarding. An employee who joins the company believing the employer medical benefit covers everything they will ever need is an employee who has not been told the truth about their benefit. Communicating clearly that the employer policy covers acute hospitalisation up to defined limits, and that a personal Integrated Shield Plan is the appropriate complement for long-term personal health protection, is the honest and responsible framing of what is provided.
You can read more about our Group Medical cover on the products page and about employee benefits programme design in our posts on Structuring an Employee Benefits Package in Singapore and Why Employees Are Not Using Their Medical Benefits.
If you are an employer reviewing your group medical programme and would like to understand how it responds to chronic illness scenarios, or how to communicate the limits of the programme to your workforce more clearly, we would be glad to work through it with you. For personal Integrated Shield Plan advice, employees should consult a qualified financial adviser.
This article provides general information only. It is not insurance or financial advice. IP deductible and rider figures cited reflect MOH's requirements effective 1 April 2026. Dialysis cost and subsidy information sourced from CNA and the Kidney Dialysis Foundation. Policy availability, terms, conditions, and exclusions vary by insurer and product, and cover is subject to the full policy wording. Please contact TZY CO for advice on your specific insurance situation.